Changes in morphofunctional parameters of the isolated heart subjected to global ischemia-reperfusion were studied in SPF Wistar rats with antibiotic-induced dysbiosis (AID) treated with lyophilized yeast Saccharomyces boulardii and inactivated probiotic bacteria Lactobacillus reuteri KR2017. In contrast to S. boulardii, correction of dysbiosis with L. reuteri KR2017 against the background of gastric hypersecretion and standard antimicrobial therapy led to an increase in fat content and a decrease in free and bound water in tissues and to a significant reduction in myocardial infarct size caused by ischemia/ reperfusion injury.
Similar content being viewed by others
References
Averina OV, Ermolenko EI, Ratushniy AYu, Tarasova EA, Borschev YuYu, Leontieva GF, Kramskaya TA, Kotyleva MP, Danilenko VN, Suvorov AN. Influence of probiotics on cytokine production in the in vitro and in vivo systems. Med. Immunol. 2015;17(5):443-454. Russian.
Borshcev YuYu, Minasian SM, Burovenko IYu, Ermolenko EI, Suvorov AN, Galagudza MM. Influence of probiotic strain E. faecium L3 on myocardial tolerance to ischemia-reperfusion injury in the model of antibiotic-induced intestinal dysbiosis. Ross. Fiziol. Zh. 2016;102(11):1323-1332. Russian.
Vasil’ev YuV. Acid-dependent gastrointestinal diseases and coronary heart disease. Lech. Vrach. 2006;(1):50-55. Russian.
Korolev DV, Aleksandeov IV, Galagudza MM, Syrenskii AV, Sonin DL, Egorova EI. Automation of data acquisition and processing in a physiological experiment. Regionar. Krovoobr. Mikrotsirk. 2008;7(2):79-84. Russian.
Minasyan SM, Badrikhanova LR, Galagudza MM, Kurapeev DI. Comparative study of the protective effect of hypothermia, ischemic preconditioning, and modified cardioplegic solutions in ischemia/reperfusion of isolated rat heart. Regionar. Krovoobr. Mikrotsirk. 2008;7(2):72-78. Russian.
Tkachenko EI, Skazyvaeva EV, Avalueca EB, Sitkin SI. The use of Saccharomyces boulardii (Enterol®) in therapeutic and gastroenterological practice. Gastroenterol. Sankt-Peterburga. 2010;(1):23-24. Russian.
Uspenskii YuP, Fominykh YuA, Ivanov SV, Menaker IO. Evolution in eradication therapy of HP-associated diseases. Going beyond the standards. Russ. Med. Zh. 2016;24(17):1144-1152. Russian.
Shlyakhto EV, Petrishchev NN, Galagudza MM, Vlasov TD, Nifontov EM. Cardioprotection: fundamental and clinical aspects. St. Petersburg, 2013. Russian.
Lam V, Su J, Hsu A, Gross GJ, Salzman NH, Baker JE. Intestinal microbial metabolites are linked to severity of myocardial infarction in rats. PLoS One. 2016;11(8):e0160840. doi: https://doi.org/10.1371/journal.pone.0160840.
Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012;26(4):1727-1735.
Postler TS, Ghosh S. Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 2017;26(1):110-130.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 10, pp. 426-430, October, 2018
Rights and permissions
About this article
Cite this article
Borshchev, Y.Y., Sinitsa, A.V., Zakharchenko, M.M. et al. Effect of Antiobiotic-Induced Disbiosis and Its Correction with Probiotics on Myocardial Tolerance to Ischemia-Reperfusion Injury in SPF Rats. Bull Exp Biol Med 166, 440–443 (2019). https://doi.org/10.1007/s10517-019-04368-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-019-04368-5